Work

Race/ethnicity does not impact surgical management or clinical outcomes among insured patients with dermatofibrosarcoma protuberans

Year: 2024

Type: article

Abstract: To the Editor: Given the rarity of dermatofibrosarcoma protuberans (DFSP), there is limited literature exploring the impact of race/ethnicity on clinical outcomes. Previous studies suggest that individuals of Black race exhibit worse survival outcomes. However, these analyses were constrained in scope, encompassing both uninsured and insured patients and focusing only on patient populations categorized as “Black” or “White.”1,2 Given the potential confounding effect of insurance status and limited demographic representation, we sought to examine the epidemiology, treatment characteristics, and clinical outcomes among a racially diverse cohort of insured individuals diagnosed with DFSP.

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2024.07.1469

Authors: Amanda H. Rosenthal, Geena Conde, Jing Zhang, Nima M. Gharavi, Jeremy Man

Institutions: Cedars-Sinai Medical Center, University of California, Los Angeles, Kaiser Permanente, Los Angeles Medical Center

Language: English

Topic: Soft tissue tumor case studies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: hybrid

Estimated APC paid: $4,200